New technology to assist research and genetic drug delivery

Wednesday, March 24, 2010 - 17:35 in Biology & Nature

Techulon, Inc., and University of Cincinnati sign worldwide exclusive license agreements to manufacture and sell novel reagents used for research and therapeutic delivery of nucleic acids.

Read the whole article on Physorg

More from Physorg

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net